Role and Function of Matrix Metalloproteinases in the Differentiation and Biological Characterization of Mesenchymal Stem Cells

Barry, 2004, Mesenchymal stem cells: Clinical applications and biological characterization, Int J Biochem Cell Biol, 36, 568, 10.1016/j.biocel.2003.11.001

Minguell, 2001, Mesenchymal stem cells, Exp Biol Med (Maywood), 226, 507, 10.1177/153537020122600603

Roufosse, 2004, Circulating mesenchymal stem cells, Int J Biochem Cell Biol, 36, 585, 10.1016/j.biocel.2003.10.007

Friedenstein, 1961, Osteogenic activity of transplanted transcriptional epithelium, Acta Anat (Basel), 45, 31, 10.1159/000141739

Baksh, 2004, Adult mesenchymal stem cells: Characterization, differentiation, and application in cell and gene therapy, J Cell Mol Med, 8, 301, 10.1111/j.1582-4934.2004.tb00320.x

Bianco, 2001, Bone marrow stromal stem cells: Nature, biology, and potential applications, Stem Cells, 19, 180, 10.1634/stemcells.19-3-180

Zipori, 2004, Mesenchymal stem cells: Harnessing cell plasticity to tissue and organ repair, Blood Cells Mol Dis, 33, 211, 10.1016/j.bcmd.2004.08.019

Nelson, 2000, Matrix metalloproteinases: Biologic activity and clinical implications, J Clin Oncol, 18, 1135, 10.1200/JCO.2000.18.5.1135

Vu, 2000, Matrix metalloproteinases: Effectors of development and normal physiology, Genes Dev, 14, 2123, 10.1101/gad.815400

Mannello, 2001, Tissue inhibitors of metalloproteinases and programmed cell death: Conundrums, controversies and potential implications, Apoptosis, 6, 479, 10.1023/A:1012493808790

Mannello, 2005, Multiple roles of matrix metal-loproteinases during apoptosis, Apoptosis, 10, 19, 10.1007/s10495-005-6058-7

Mannello, 2005, Matrix metalloproteinase inhibitors as anticancer therapeutics, Curr Cancer Drug Targets, 5, 285, 10.2174/1568009054064615

Mott, 2004, Regulation of matrix biology by matrix metalloproteinases, Curr Opin Cell Biol, 16, 558, 10.1016/j.ceb.2004.07.010

Silva, 2003, The profile of gene expression of human marrow mesenchymal stem cells, Stem Cells, 21, 661, 10.1634/stemcells.21-6-661

Panepucci, 2004, Comparison of gene expression of umbilical cord vein and bone marrow-derived mesenchymal stem cells, Stem Cells, 22, 1263, 10.1634/stemcells.2004-0024

Steck, 2005, Induction of invertebral disc-like cells from adult mesenchymal stem cells, Stem Cells, 23, 403, 10.1634/stemcells.2004-0107

Mannello, 2005, Are matrix metalloproteinases the missing link, ISJ, 2, 69

Visse, 2003, Matrix metalloproteinases and tissue inhibitors of metalloproteinases, Circ Res, 92, 827, 10.1161/01.RES.0000070112.80711.3D

Lewis, 2000, Gelatinase-B (matrix metalloproteinase-9; MMP-9) secretion is involved in the migratory phase of human and murine muscle cell cultures, J Muscle Res Cell Motil, 21, 223, 10.1023/A:1005670507906

Philips, 1990, Migration of myogenic cells in rat extensor digitorum longus muscle studied with a split autograft model, Cell Tissue Res, 262, 81, 10.1007/BF00327748

Galli, 2000, Skeletal myogenic potential of human and mouse neural stem cells, Nat Neurosci, 3, 986, 10.1038/79924

El Fahime, 2000, In vivo migration of transplanted myoblasts requires matrix metalloproteinase activity, Exp Cell Res, 258, 279, 10.1006/excr.2000.4962

Guerin, 1995, Synthesis and secretion of matrix-degrading metalloproteases by human skeletal muscle satellite cells, Dev Dyn, 202, 91, 10.1002/aja.1002020109

Caron, 1999, Increased myogenic potential and fusion of matrilysin-expressing myoblasts transplanted in mice, Cell Transplant, 8, 465, 10.1177/096368979900800502

Allen, 2003, Growth factor stimulation of matrix metalloproteinase expression and myoblast migration and invasion in vitro, Am J Physiol Cell Physiol, 284, C805, 10.1152/ajpcell.00215.2002

Roach, 2002, Up-regulation of MMP-2 and MMP-9 leads to degradation of type IV collagen during skeletal muscle reperfusion injury; protection by the MMP inhibitor, doxycycline, Eur J Vasc Endovasc Surg, 23, 260, 10.1053/ejvs.2002.1598

Schoser, 2002, Matrix metalloproteinase in inflammatory myopathies: Enhanced immunoreactivity near atrophic myofibers, Acta Neurol Scand, 105, 309, 10.1034/j.1600-0404.2002.1o104.x

Canete Soler, 1995, MMP-9 (gelatinase B) mRNA is expressed during mouse neurogenesis and may be associated with vascularization, Brain Res Dev Brain Res, 88, 37, 10.1016/0165-3806(95)00079-S

Yong, 2001, Metalloproteinases in biology and pathology of the nervous system, Nat Rev Neurosci, 2, 502, 10.1038/35081571

Vaillant, 1999, Spatiotemporal expression patterns of metalloproteinases and their inhibitors in the postnatal developing rat cerebellum, J Neurosci, 19, 4994, 10.1523/JNEUROSCI.19-12-04994.1999

Sekine-Aizawa, 2001, Matrix metalloproteinase (MMP) system in brain: Identification and characterization of brain-specific MMP highly expressed in cerebellum, Eur J Neurosci, 13, 935, 10.1046/j.0953-816x.2001.01462.x

Frolichsthal-Schoeller, 1999, Expression and modulation of matrix metalloproteinase-2 and tissue inhibitors of metalloproteinases in human embryonic CNS stem cells, Neuroreport, 10, 345, 10.1097/00001756-199902050-00025

Oh, 1999, Matrix metalloproteinase-9/ gelatinase B is required for process outgrowth by oligodendrocytes, J Neurosci, 19, 8464, 10.1523/JNEUROSCI.19-19-08464.1999

Shapiro, 1993, Cloning and characterization of a unique elastolytic metalloproteinase produced by human alveolar macrophages, J Biol Chem, 268, 23824, 10.1016/S0021-9258(20)80459-1

Larsen, 2004, The expression of matrix metalloproteinase-12 by oligodendrocytes regulates their maturation and morphological differentiation, J Neurosci, 24, 7597, 10.1523/JNEUROSCI.2092-04.2004

Chambaut-Guerin, 2000, Induction of matrix metalloproteinase MMP-9 (92-kDa gelatinase) by retinoic acid in human neuroblastoma SKNBE cells: Relevance to neuronal differentiation, J Neurochem, 74, 508, 10.1046/j.1471-4159.2000.740508.x

Zuo, 1998, Neuronal matrix metalloproteinase-2 degrades and inactivates a neurite-inhibiting chondroitin-sulphate proteoglycan, J Neurosci, 18, 5203, 10.1523/JNEUROSCI.18-14-05203.1998

Webber, 2002, Metalloproteases and guidance of retinal axons in the developing visual system, J Neurosci, 22, 8091, 10.1523/JNEUROSCI.22-18-08091.2002

Rathke-Hartlieb, 2000, Elevated expression of membrane type 1 metalloproteinase (MT1-MMP) in reactive astrocytes following neurodegeneration in mouse central nervous system, FEBS Lett, 481, 227, 10.1016/S0014-5793(00)02011-1

Tuckermann, 2000, Collagenase-3 (MMP-13) and integral membrane protein 2a (Itm2a) are marker genes of chondrogenic/osteoblastic cells in bone formation: Sequential temporal, and spatial expression of Itm2a, alkaline phosphatase, MMP-13, and osteocalcin in the mouse, J Bone Miner Res, 15, 1257, 10.1359/jbmr.2000.15.7.1257

Shinmei, 1991, Production of cytokines by chondrocytes and its role in proteoglycan degradation, J Rheumatol Suppl, 27, 89

Jimènez, 1999, Collagenase 3 is a target of Cbfa1, a transcription factor of the runt gene family involved in bone formation, Mol Cell Biol, 19, 4431, 10.1128/MCB.19.6.4431

Jiménez, 2001, A regulatory cascade involving retinoic acid, Cbfa1, and matrix metalloproteinases is coupled to the development of a process of perichondral invasion and osteogenic differentiation during bone formation, J Cell Biol, 155, 1333, 10.1083/jcb.200106147

Zhou, 2000, Impaired endochondral ossification and angiogenesis in mice deficient in membrane-type matrix metalloproteinase I, Proc Natl Acad Sci U S A, 97, 4052, 10.1073/pnas.060037197

Engsig, 2000, Matrix metalloproteinase 9 and vascular endothelial growth factor are essential for osteoclast recruitment into developing long bones, J Cell Biol, 151, 879, 10.1083/jcb.151.4.879

Holmbeck, 1999, MT1-MMP-deficient mice develop dwarfism, osteopenia, arthritis, and connective tissue disease due to inadequate collagen turnover, Cell, 99, 81, 10.1016/S0092-8674(00)80064-1

Murphy, 1999, Evaluation of some newer matrix metalloproteinases, Ann N Y Acad Sci, 878, 25, 10.1111/j.1749-6632.1999.tb07672.x

Vu, 1998, MMP-9/gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytes, Cell, 93, 411, 10.1016/S0092-8674(00)81169-1

Sakai, 2001, Tumor necrosis factor alpha induces expression of genes for matrix degradation in human chondrocyte-like HCS-2/8 cells through activation of NF-kappaB: Abrogation of the tumor necrosis factor alpha effect by proteasome inhibitors, J Bone Miner Res, 16, 1272, 10.1359/jbmr.2001.16.7.1272

Cancedda, 1995, Chondrocyte differentiation, Int Rev Cytol, 159, 265, 10.1016/S0074-7696(08)62109-9

Lee, 2004, Chondrogenic differentiation of mesenchymal stem cells and its clinical applications, Yonsei Med J, 45, 41, 10.3349/ymj.2004.45.Suppl.41

Inui, 1999, Matrix metalloproteinases and lysosomal cysteine proteases in osteoclasts contribute to bone resorption through distinct modes of action, Biochem Biophys Res Commun, 258, 173, 10.1006/bbrc.1999.0473

Cronwright, 2005, Cancer/testis antigen expression in human mesenchymal stem cells: Down-regulation of SSX impairs cell migration and matrix metalloproteinase 2 expression, Cancer Res, 65, 2207, 10.1158/0008-5472.CAN-04-1882

Batouli, 2003, Comparison of stem-cell-mediated osteogenesis and dentinogenesis, J Dent Res, 82, 976, 10.1177/154405910308201208

Holmbeck, 2005, The metalloproteinase MT1-MMP is required for normal development and maintenance of osteocyte processes in bone, J Cell Sci, 118, 147, 10.1242/jcs.01581

Karsdal, 2002, Matrix metalloproteinase-dependent activation of latent transforming growth factor-beta controls the conversion of osteoblasts into osteocytes by blocking osteoblast apoptosis, J Biol Chem, 277, 44061, 10.1074/jbc.M207205200

Karsdal, 2004, Matrix metalloproteinases (MMPs) safeguard osteoblasts from apoptosis during transdifferentiation into osteocytes: MT1-MMP maintains osteocyte viability, DNA Cell Biol, 23, 155, 10.1089/104454904322964751

Holmes, 2004, Chemically modified tetracyclines act through multiple mechanisms directly on osteoclast precursors, Bone, 35, 471, 10.1016/j.bone.2004.02.028

Cheung, 2005, Increased expression of G11alpha in osteoblastic cells enhances parathyroid hormone activation of phospholipase C and AP-1 regulation of matrix metalloproteinase-13 mRNA, J Cell Physiol, 204, 336, 10.1002/jcp.20299

Geoffroy, 2004, In vivo inhibition of osteoblastic metalloproteinases leads to increased trabecular bone mass, J Bone Miner Res, 19, 811, 10.1359/jbmr.040119

Stamenkovic, 2003, Extracellular matrix remodelling: The role of matrix metalloproteinases, J Pathol, 200, 448, 10.1002/path.1400

Lijnen, 2002, Matrix metalloproteinase inhibition impairs adipose tissue development in mice, Arterioscler Thromb Vasc Biol, 22, 374, 10.1161/hq0302.104522

Kubo, 2000, Organization of extracellular matrix components during differentiation of adipocytes in long-term culture, In Vitro Cell Dev Biol Anim, 36, 38, 10.1290/1071-2690(2000)036<0038:OOEMCD>2.0.CO;2

Brown, 1997, Role of the matrixin MMP-2 in multicellular organization of adipocytes cultured in basement membrane components, Am J Physiol, 272, C937, 10.1152/ajpcell.1997.272.3.C937

Johnson, 1994, Inhibition of angiogenesis by tissue inhibitor of metalloproteinase, J Cell Physiol, 160, 194, 10.1002/jcp.1041600122

Lund, 1996, Two distinct phases of apoptosis in mammary gland involution: Proteinase-independent and -dependent pathways, Development, 122, 181, 10.1242/dev.122.1.181

Alexander, 2001, Stromelysin-1 regulates adipogenesis during mammary gland involution, J Cell Biol, 152, 693, 10.1083/jcb.152.4.693

Bouloumié, 2001, Adipocyte produces matrix metalloproteinases 2 and 9: Involvement in adipose differentiation, Diabetes, 50, 2080, 10.2337/diabetes.50.9.2080

Bourlier, 2005, Protease inhibitor treatments reveal specific involvement of matrix metalloproteinase-9 in human adipocyte differentiation, J Pharmacol Exp Ther, 312, 1272, 10.1124/jpet.104.077263

Chavey, 2003, Matrix metalloproteinases are differently expressed in adipose tissue during obesity and modulate adipocyte differentiation, J Biol Chem, 278, 11888, 10.1074/jbc.M209196200